I can tell you for sure that Novartis is well aware of and is following the progress of OPT302.
It has been on their radar since the the phase 2 trial began.
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea's OPT-302 Granted Fast-Track for wet AMD
Ann: Opthea's OPT-302 Granted Fast-Track for wet AMD, page-29
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
52.0¢ |
Change
-0.025(4.59%) |
Mkt cap ! $658.6M |
Open | High | Low | Value | Volume |
54.5¢ | 54.5¢ | 51.5¢ | $425.3K | 807.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 18364 | 51.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.0¢ | 6920 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 22804 | 0.515 |
11 | 75313 | 0.510 |
10 | 81781 | 0.505 |
14 | 108940 | 0.500 |
6 | 175355 | 0.495 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 23896 | 13 |
0.525 | 30867 | 6 |
0.530 | 89076 | 8 |
0.535 | 16153 | 5 |
0.540 | 71138 | 10 |
Last trade - 12.59pm 28/08/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
SPONSORED BY The Market Online